Skip to main content
Clinical Trials/JPRN-UMIN000006143
JPRN-UMIN000006143
Completed
Phase 3

Exploratory analysis of serum and urine biomarkers associated with nausea and vomittings induced by highly emetogenic chemotherapy (Biomarker study of TRIPLE)

Division of thoracic oncology, Shizuoka Cancer Center0 sites80 target enrollmentAugust 10, 2011
ConditionsThoracic tumor

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Thoracic tumor
Sponsor
Division of thoracic oncology, Shizuoka Cancer Center
Enrollment
80
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Division of thoracic oncology, Shizuoka Cancer Center

Eligibility Criteria

Inclusion Criteria

  • 1\. patients who registered the TRIPLE study.
  • 2\. patients treated at division of thoracic oncology, Shizuoka Cancer Center.
  • 3\. all subjects must be able to provide informed,written consent prio to entry.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials